Circ_0026134 promotes <scp>NSCLC</scp> progression by the <scp>miR</scp> ‐3619‐5p/ <scp>CHAF1B</scp> axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circ_0026134 promotes NSCLC progression by the miR ‐3619‐5p/ CHAF1B axis

Published:2022-01-05 Issue:4 Volume:13 Page:582-592
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Ge Liang¹,Tan Wei¹,Li Guangcai¹,Gong Nianjin¹,Zhou Long¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture Enshi China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14301

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

3. The biology and management of non-small cell lung cancer

4. The biogenesis, biology and characterization of circular RNAs

5. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EIF4A3‐Induced CircDHTKD1 regulates glycolysis in non‐small cell lung cancer via stabilizing PFKL;Journal of Cellular and Molecular Medicine;2024-07

2. Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities;Cancer Genomics - Proteomics;2023-11-30

3. Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy;Environmental Research;2023-10

4. Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p;Translational Lung Cancer Research;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3